Clinical stage company developing novel drugs based on its unique ability to de-code molecular interactions in the gut microbiome impacting human health.
Location: France, Ile-de-France, Paris
Total raised: $128.1M
Founded date: 2011
Investors 3
| Date | Name | Website |
| - | Takeda Ven... | takeda.com |
| - | SymBiosis | symbiosis.... |
| - | Omnes Capi... | omnescapit... |
Funding Rounds 5
| Date | Series | Amount | Investors |
| 25.06.2020 | Series E | $52.6M | - |
| 04.01.2018 | Series D | $38.61M | - |
| 20.04.2016 | Series C | $16.39M | - |
| 01.05.2014 | Series B | $13.87M | - |
| 23.03.2012 | Series A | $6.63M | - |
Mentions in press and media 19
| Date | Title | Description | Source |
| 25.04.2024 | Enterome to Present Clinical Data on EO2463 in B-cell Lympho... | Poster presentation to highlight updated data from ongoing Phase 1/2 of EO2463 monotherapy and in co... | einpresswi... |
| 17.04.2024 | Enterome Announces Successful Completion of Phase 2 ROSALIE ... | EO2401, a pioneering OncoMimics™ peptide-based immunotherapy, has demonstrated rapid activation and ... | einpresswi... |
| 06.03.2024 | Enterome Announces Upcoming Presentation on OncoMimics™ Appr... | - | globenewsw... |
| 13.11.2023 | Enterome to Present Updated Data From Phase 1/2 ROSALIE Tria... | Oral Presentation at SNO will feature updated results from the Phase 1/2 EOGBM1-18/ROSALIE study PAR... | einpresswi... |
| 31.05.2023 | Enterome announces sustained positive clinical outcomes with... | /EIN News/ -- Updated clinical data highlight promising efficacy and sustained CD8+ T cell expansion... | einpresswi... |
| 12.12.2022 | Enterome completes patient enrollment of Phase 2 ROSALIE stu... | EO2401 is a first-in-class OncoMimics™ peptide-based immunotherapy able to rapidly activate and sign... | einpresswi... |
| 07.12.2022 | Enterome presents two posters on Phase 2 data of its lead im... | Enterome will also be presenting another poster on the therapeutic development of OncoMimics™ peptid... | einpresswi... |
| 25.06.2021 | Roth Capital Partners to Host a Virtual Healthcare Private C... | NEWPORT BEACH, Calif., June 25, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Roth Capital Partners (... | marketscre... |
| 24.08.2020 | These 10 ambitious French tech startups obtained highest VC ... | Undoubtedly, the COVID-19 pandemic outbreak has impacted several businesses across the world causing... | siliconcan... |
| 26.06.2020 | Biopharma business Enterome scores €46.3M Series E | Enterome has received a €46.3 million investment. New backers SymBiosis and Takeda Pharmaceutical jo... | pitchbook.... |
Show more